Etybenzatropine
From Wikipedia, the free encyclopedia
|
Etybenzatropine
|
|
| Systematic (IUPAC) name | |
| (1R,5R)-3-(dicyclohexylmethoxy)-8-ethyl- 8-azabicyclo[3.2.1]octane |
|
| Identifiers | |
| CAS number | |
| ATC code | N04 |
| PubChem | |
| Chemical data | |
| Formula | C22H27NO |
| Mol. mass | 321.456 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Oral, IM, IV |
Etybenzatropine (or ethybenztropine) is a anticholinergic used as an anti-parkinson drug. It is a derivative of benzatropine.
|
|||||||||||

